EpiCast Report: Dermatophytic Onychomycosis - Epidemiology Forecast to 2022



Summary



Dermatophytic onychomycosis (DO) is an infection of the nail fold or nail plate with dermatophytes, a type of fungus, especially Trichophyton rubrum, Trichophyton mentagrophytes, and Epidermophyton flocossom (Sterry et al., 2006). DO begins as a white/yellow spot under the tip of the nail. As the infection spreads deeper, it causes further discoloration and thickening of the nail, resulting in nail disfigurement and pain/discomfort.

The high worldwide prevalence of DO is primarily due to changes in factors relating to lifestyle, customs, and culture. The incidence and prevalence of DO in the EU was stable over a period of 30 years between the 1960s and 1990s due to a decline in industries such as coal mining, representing decreased use of industrial baths, while simultaneously there has been an increase in prevalence resulting from the use of communal recreational facilities, which led to a constant incidence of DO (Roberts, 1992; Seebacher et al., 2008). In Japan, the traditional Japanese practice of walking barefoot in the house, which facilitates the spread of the infection to family members, is the primary reason for the especially high prevalence and intensity of toenail fungal disease in Japan (Nishimoto, 2006; Watanabe et al., 2010).



Scope


- The Dermatophytic Onychomycosis (DO) EpiCast Report provides an overview of the risk factors and global trends of DO in the seven major markets (US, France, Germany, Italy, Spain, UK, and Japan).
- It also includes a 10-year epidemiology forecast of the prevalent cases of DO, segmented by sex, and age (15–29 years, 30–49 years, 50–69 years, and >70 years) in these markets.



Reasons to buy


- Develop business strategies by understanding the trends shaping and driving the global DO market.
- Quantify patient populations in the global DO market to improve product design, pricing, and launch plans.
- Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for DO therapeutics in each of the markets covered.

Table Of Contents

Table of Contents

1 Table of Contents 4
1.1 List of Tables 5
1.2 List of Figures 6
2 Introduction 7
2.1 Catalyst 7
3 Epidemiology 8
3.1 Risk Factors and Comorbidities 8
3.1.1 Poor peripheral circulation is greater in older men 9
3.1.2 Household contact with other DO patients increases risk of infection 2.5 times 9
3.1.3 Immunosuppression increases susceptibility to DO infections 10
3.1.4 Prevalence of dermatophytic onychomycosis is higher in diabetics than in non-diabetics 11
3.2 Global Trends 12
3.2.1 US 12
3.2.2 5EU 13
3.2.3 Japan 14
3.3 Forecast Methodology 15
3.3.1 Sources Used 16
3.3.2 Forecast Assumptions and Methods 18
3.3.3 Sources Not Used 20
3.4 Epidemiology Forecast (2012-2022) 21
3.4.1 Prevalent Cases of Dermatophytic Onychomycosis 21
3.4.2 Age-Specific Prevalent Cases of Dermatophytic Onychomycosis 23
3.4.3 Sex-Specific Prevalent Cases of Dermatophytic Onychomycosis 25
3.4.4 Age-Standardized Prevalence of Dermatophytic Onychomycosis 27
3.5 Discussion 28
3.5.1 Limitations of the Analysis 29
3.5.2 Strengths of the Analysis 29
4 Appendix 30
4.1 Bibliography 30
4.2 About the Authors 33
4.2.1 Epidemiologists 33
4.2.2 Reviewers 33
4.2.3 Global Director of Epidemiology and Clinical Trials Analysis 34
4.2.4 Global Head of Healthcare 35
4.3 About GlobalData 35
4.4 About EpiCast 36
4.5 Contact Us 36
4.6 Disclaimer 36



List of Tables

Table 1: Risk Factors and Comorbidities for Dermatophytic Onychomycosis 8
Table 2: Seven Major Markets, Sources of Dermatophytic Onychomycosis Prevalence Data 15
Table 3: Seven Major Markets, Total Prevalent Cases of Dermatophytic Onychomycosis, Ages ?15 Years, Men and Women, Selected Years, 2012-2022 21
Table 4: Seven Major Markets, Total Prevalent Cases of Dermatophytic Onychomycosis, by Age, Men and Women, N = Millions (Row %), 2012 23
Table 5: Seven Major Markets, Total Prevalent Cases of Dermatophytic Onychomycosis, by Sex, Ages ? 15 Years, N=Millions, (Row %), 2012 25



List of Figures

Figure 1: Seven Major Markets, Total Prevalent Cases of Dermatophytic Onychomycosis, Ages ?15 Years, Men and Women, Selected Years, 2012-2022 22
Figure 2: Seven Major Markets, Total Prevalent Cases of Dermatophytic Onychomycosis, by Age, Men and Women, N = Millions, 2012 24
Figure 3: Seven Major Markets, Total Prevalent Cases of Dermatophytic Onychomycosis, by Sex, Ages ? 15 Years, N = Millions, 2012 26
Figure 4: Seven Major Markets, Age-Standardized Prevalence of Dermatophytic Onychomycosis, Ages ?15 Years, by Sex , 2012 27

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers

Analysis of the Global Infectious Disease Diagnostics Market

Analysis of the Global Infectious Disease Diagnostics Market

  • $ 10 000
  • Industry report
  • September 2014
  • by Frost & Sullivan

Molecular Methods Present Significant Opportunities This deliverable provides research and analysis of the global infectious disease diagnostics market. It includes an in-depth analysis of revenue forecast ...

OpportunityAnalyzer: Chronic Lymphocytic Leukemia - Opportunity Analysis and Forecasts to 2018

OpportunityAnalyzer: Chronic Lymphocytic Leukemia - Opportunity Analysis and Forecasts to 2018

  • $ 7 995
  • Industry report
  • June 2014
  • by Global Data

OpportunityAnalyzer: Chronic Lymphocytic Leukemia - Opportunity Analysis and Forecasts to 2018 Summary Chronic lymphocytic leukemia (CLL), the most common form of adult leukemia, is caused by the uncontrolled ...

Frontier Pharma: Breast Cancer - Identifying and Commercializing First-in-Class Innovation

Frontier Pharma: Breast Cancer - Identifying and Commercializing First-in-Class Innovation

  • $ 6 995
  • Industry report
  • July 2014
  • by GBI Research

Frontier Pharma: Breast Cancer - Identifying and Commercializing First-in-Class Innovation Summary Exceptionally Large and Innovative Pipeline The breast cancer pipeline is the largest in the pharmaceutical ...

Bcc Research Bitopertin Forecast

August 2014 $ 5 500

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.